Medicine and Dentistry
Colorectal Cancer Screening
90%
Colonoscopy
74%
Occult Blood Test
59%
Colorectal Cancer
45%
Screening
40%
Adenoma
29%
Colorectal Carcinoma
26%
Malignant Neoplasm
25%
Biological Marker
21%
Cohort Analysis
17%
Cross Sectional Study
12%
Laparoscopic Surgery
12%
Endoscopy
11%
Prevalence
11%
Observational Study
11%
Circulating Tumor DNA
10%
Disease
10%
Sensitivity and Specificity
9%
Neoplasm
8%
High Risk Population
7%
Colon
7%
Colon Cancer
6%
Polyp
6%
Intestine Preparation
6%
Charlson Comorbidity Index
6%
Thromboprophylaxis
6%
Diagnosis
6%
Recurrent Disease
6%
Surgery
5%
Endoscope
5%
Cell Function
5%
Fluid Balance
5%
All Cause Mortality
5%
Oncologist
5%
Intermediate Care
5%
Colorectal Tumor
5%
Fluid Therapy
5%
Insulin Sensitivity
5%
Colorectal Surgery
5%
Hemicolectomy
5%
Anastomosis Leakage
5%
Stroke Volume
5%
Guaiacum
5%
COVID-19
5%
Hemoglobin Determination
5%
Gynecology
5%
Phlebothrombosis
5%
Triage
5%
Endoscopic Surgery
5%
Beta Cell
5%
Keyphrases
Colorectal Cancer Screening
100%
Colorectal Cancer
65%
Colonoscopy
46%
Fecal Immunochemical Test
37%
Denmark
27%
Screen-detected
17%
National Cohort Study
16%
Obese Subjects
15%
Blood Biomarkers
13%
Early Detection
13%
Insulin-like
13%
Blood-based
11%
Growth Hormone Release
10%
Type 1 Diabetic Patient
10%
Population Screening
9%
Growth Factors
9%
Adenoma
9%
Fecal Occult Blood Test
9%
Body Composition
8%
Confidence Interval
8%
European Guidelines
8%
Population-based
8%
Precursor Lesions
8%
Endoscopy
8%
GH Release
7%
Cause of Death
7%
Hypoglycemia
7%
Comorbidity
6%
Laparoscopic Surgery
6%
Thromboprophylaxis
6%
Serum Biomarkers
6%
Clinical High Risk
6%
Short-term Mortality
6%
Cancer-associated Proteins
6%
Risk Factors
6%
COVID-19
6%
Non-participation
6%
Impact of Screening
6%
Charlson Comorbidity Index
6%
Release Profile
5%
Asthma
5%
Diagnostic Colonoscopy
5%
IGF-binding protein-3
5%
Bowel Preparation
5%
Test Screening
5%
Triage
5%
Relative Risk
5%
Medical Complications
5%
Blood Samples
5%
Glucose Recovery
5%
